Gene · 8506
CNTNAP1: contactin associated protein 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CNTNAP1: contactin associated protein 1. Genes, record 8506. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8506
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P78357 | Contactin-associated protein 1 | 1,384 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents29
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 2374 | P78357 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 281 | P78357 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1947 | P78357 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 118 | P78357 | Espacenet |
| EP 4641203 A2 | 2025-10-29 | 77 | P78357 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1069 | P78357 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1069 | P78357 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 281 | P78357 | Espacenet |
| JP 2025517967 A | 2025-06-12 | 77 | P78357 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1947 | P78357 | Espacenet |
1 to 10 of 29
See all 29 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,045
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CNTNAP1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 23 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 10 | 2025 |
| P01CA018029 | Adult Leukemia Research Center | 6 | 2025 |
| P30CA062203 | Cancer Center Support Grant | 4 | 2025 |
| T32CA009054 | A Training Program for Interdisciplinary Cancer Research | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
| P30DK034854 | Integrated Epithelial and Muscosal Biology | 3 | 2025 |
| T32CA009109 | Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies | 3 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 1,045Source NIH's project files
See all 1,045 nih grantsPapers1,771
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dual-Driver Myeloproliferative Neoplasm: Concurrent p190 BCR::ABL1 CML and JAK2 V617F Mutation: A Case Report and Literature Review. | Case Rep Hematol | 2026 | 42781115 | PubTator, text mining | PubMed |
| Pathophysiology and Emerging Therapies in Chronic Inflammation Demyelinating Polyneuropathy. | Intern Med | 2026 | 42749655 | PubTator, text mining | PubMed |
Successful induction of remission with azacitidine, venetoclax, and dasatinib followed by allogeneic hematopoietic stem cell transplantation in a patient with Philadelphia chromosome-positive mixed phenotype acute leukemia (B/myeloid): a case report. | Front Med (Lausanne) | 2026 | 42746482 | PubTator, text mining | PubMed |
| Revisiting Asciminib Resistance: From Binding Affinity to Allosteric Disruption in BCR::ABL1 Leukemias. | Turk J Haematol | 2026 | 42706725 | PubTator, text mining | PubMed |
| BCR::ABL1 e1a2 (p190)-Positive Myeloid Blast Neoplasm: Diagnostic Challenges in Distinguishing De Novo Acute Myeloid Leukemia From Previously Unrecognized Chronic Myeloid Leukemia in the Blast Phase. | Cureus | 2026 | 42667018 | PubTator, text mining | PubMed |
| Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi-LMC study. | Hemasphere | 2026 | 42549430 | PubTator, text mining | PubMed |
| Neuro-renal syndrome (NRS) in autoimmune nodopathies and paranodopathies: A warning to consider the diagnosis when anti-node and paranode antibody tests are difficult to perform. | J Neurol Sci | 2026 | 42497634 | PubTator, text mining | PubMed |
| Autoimmune nodopathies: a clinical review. | Clin Neurophysiol | 2026 | 42492459 | PubTator, text mining | PubMed |
| An Unusual Presentation of Philadelphia Chromosome Positive B-Cell Acute Lymphoblastic Leukemia With Isolated Osteolytic Lesions at Diagnosis: A Case Report. | Case Rep Hematol | 2026 | 42472062 | PubTator, text mining | PubMed |
| Development and validation of an in-house one-step RT-qPCR method for the quantification of the BCR::ABL1 p210 transcripts. | Sci Rep | 2026 | 42457813 | PubTator, text mining | PubMed |
1 to 10 of 1,771
See all 1,771 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8506
GET https://conductscience.org/api/genes/v1/8506/patents?page=2